Search research articles
Contact Us
Filters
Showing results (71-80 of 77) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 77 results.
HIV Medicine
|
January 22, 2003
Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study
M Law, N Friis-Møller, R Weber, et al.
HIV Medicine
|
May 21, 2014
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations
K Petoumenos, P Reiss, L Ryom, et al.
AIDS (London, England)
|
August 19, 2004
Cardio- and cerebrovascular events in HIV-infected persons
A d'Arminio, C A Sabin, A N Phillips, et al.
The Journal of Infectious Diseases
|
March 5, 2004
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
E Fontas, F van Leth, C A Sabin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 5, 1999
A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS
D L Cohn, E J Fisher, G T Peng, et al.
Neurology
|
August 13, 2010
Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons
E J Wright, B Grund, K Robertson, et al.
HIV Medicine
|
July 31, 2007
Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women
N Phanuphak, T Apornpong, S Teeratakulpisarn, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 77) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 77 results.
HIV Medicine
|
January 22, 2003
Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study
M Law, N Friis-Møller, R Weber, et al.
HIV Medicine
|
May 21, 2014
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations
K Petoumenos, P Reiss, L Ryom, et al.
AIDS (London, England)
|
August 19, 2004
Cardio- and cerebrovascular events in HIV-infected persons
A d'Arminio, C A Sabin, A N Phillips, et al.
The Journal of Infectious Diseases
|
March 5, 2004
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
E Fontas, F van Leth, C A Sabin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 5, 1999
A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS
D L Cohn, E J Fisher, G T Peng, et al.
Neurology
|
August 13, 2010
Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons
E J Wright, B Grund, K Robertson, et al.
HIV Medicine
|
July 31, 2007
Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women
N Phanuphak, T Apornpong, S Teeratakulpisarn, et al.
Page
of 8